Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Deciphering Transporter-Mediated Drug Interactions Affecting Marbofloxacin Residues in Sheep Milk: From In Silico Predictions to In Vivo Validation.

Created on 29 Sep 2026

Authors

Konstantinos V Arsenopoulos, Evroula Hapeshis, Elias Papadopoulos, Manos C Vlasiou

Published in

Journal of veterinary pharmacology and therapeutics. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Veterinary drug residues in milk represent an important food safety concern, particularly under conditions of co-administration where transporter-mediated drug-drug interactions may alter residue profiles. Marbofloxacin, a fluoroquinolone antimicrobial, is actively secreted into milk through the ATP-binding cassette transporter ABCG2 (BCRP), whereas ivermectin has been reported to interact with ABC transporters. The present study integrated in silico and in vivo approaches to investigate whether ivermectin may influence marbofloxacin secretion into sheep milk through transporter-mediated mechanisms. A homology model of ovine ABCG2 was constructed using the human cryo-electron microscopy structure as a template. Molecular docking and molecular dynamics simulations were subsequently performed to evaluate ligand-transporter interactions and complex stability. Docking analysis demonstrated that ivermectin exhibited a broader and more favorable interaction profile within the ABCG2 transmembrane cavity compared with marbofloxacin, with partial overlap at residues associated with substrate recognition, particularly within the Asp129-Asp130 region. Molecular dynamics simulations confirmed stable accommodation of ivermectin within the transporter throughout the simulation period without structural destabilization of the protein. The in vivo component included lactating dairy ewes receiving marbofloxacin alone or in combination with ivermectin under routine field conditions. Milk samples collected at the predicted peak milk concentration were analyzed using a validated HPLC-PDA/MS method. Marbofloxacin was detected in all milk samples with high analytical specificity. Ewes treated with ivermectin exhibited significantly lower marbofloxacin concentrations in milk compared with animals receiving marbofloxacin alone, while significant within-animal variability between udder halves was also observed.

PMID:
42808499
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement